Precision advisory for high-stakes biotech scale
Almost twenty years of dedicated advisory translating early-stage discovery into resilient, board-ready organizational frameworks.
Align team milestones directly with clinical inflection points and regulatory submission targets.
Bespoke 1-on-1 advisory helping scientific founders evolve into seasoned biotechnology executives.
Structured development programs bridging the gap between scientific exploration and commercial delivery.
Systematic cultural frameworks designed to retain tier-one researchers through scaling and funding rounds.
Confidential executive partnering
Direct C-suite consultation tailored for seed through clinical phase II biotech ventures.
Tailored advisory structures calibrated for clinical momentum.
Select an engagement model tailored to your capitalization stage, clinical runway, and executive governance requirements.
1-on-1 CEO Advisory Retainer
Confidential sounding board and strategic counsel for founders stepping into the chief executive role.
Executive Deliverables
- Board alignment blueprints
- Founder-to-CEO transition diagnostics
- Compensation & cap table governance
Executive Team Culture Sprint
Intensive alignment sprints bridging clinical science milestones, regulatory timelines, and leadership dynamics.
Executive Deliverables
- C-Suite Operating Agreement
- Cross-functional R&D decision framework
- Cultural risk and engagement audit
Enterprise Performance Architecture
Comprehensive organizational scaling, board restructuring, and institutional governance systems.
Executive Deliverables
- Enterprise KPI cascades
- IPO readiness governance charter
- Scientific Advisory Board (SAB) reconstitution
Bespoke advisory retainers and modular governance sprints can be scoped upon initial diagnostic review.
Request custom engagement diagnosticFormulate your bespoke leadership trajectory
Partner directly with seasoned advisory leadership to align performance architecture, C-suite governance, and talent systems with high-stakes clinical and commercial milestones.
48-Hour Executive Turnaround
Initial diagnostic scoping and mandate assessment provided directly by senior leadership.
Strict Boardroom Confidentiality
All discussions and strategic mandate data remain protected under bilateral non-disclosure protocols.